title: Fibrinolysis activity promotes tumor invasiveness of B16 melanoma cell lines through a reconstituted gel matrix.
abstract: We studied the role of the fibrinolytic function in the invasiveness of murine melanoma B16F1 and F10 cells using a reconstituted matrix on a filter in a modified Boyden chamber. The main species of plasminogen activators (PAs) synthesized in cell lysates and released into conditioned media by these cells was found to be tissue-type PA (t-PA). The invasiveness of these cell lines was enhanced by adding plasminogen to the gel matrix. This enhancing effect of plasminogen was markedly suppressed by adding anti-t-PA IgG and plasmin inhibitors into the gel matrix, but less affected by anti-urokinase-type PA (u-PA) IgG, offering more evidence to the hypothesis that the activation of the fibrinolytic system by PAs plays an important role in the invasiveness of murine melanoma B16 cell lines, and indicating that t-PA contributed more than u-PA to the invasive potential of these cells into the pericellular matrix.
authors.affiliation: Department of Pathology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Mimura
authors.forename: K
authors.initials: K
authors.lastname: Sueishi
authors.forename: C
authors.initials: C
authors.lastname: Yasunaga
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
mesh_terms: D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D002460:Cell Line; D005109:Extracellular Matrix / Q000502:physiology; D005342:Fibrinolysis; D007700:Kinetics; D008546:Melanoma, Experimental / Q000201:enzymology / Q000473:pathology*; D051379:Mice; D009361:Neoplasm Invasiveness / Q000473:pathology*; D010958:Plasminogen / Q000378:metabolism; D010960:Plasminogen Activators / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology*; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D014407:Tumor Cells, Cultured; D000979:alpha-2-Antiplasmin / Q000494:pharmacology
chemical_list: D011480:Protease Inhibitors; D000979:alpha-2-Antiplasmin; D010958:Plasminogen; D007611:Aprotinin; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator